Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors

NCT07439120 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Urothelial Carcinoma (UC)

Interventions

DRUG: ⁶⁸Ga/¹⁷⁷Lu-BRP-020063

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine